Who owns TYRA BIOSCIENCES INC?
- Ticker: TYRA
- CUSIP Number: 90240b106
Tip: Access positions for across all investors
Analyze quarterly positions in Tyra Biosciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Tyra Biosciences stock
Who bought or sold TYRA BIOSCIENCES INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
RA Capital Management | 10M | $171M | 44% | Mar 2024 |
|
Boxer Capital | 6.4M | $106M | 0% | Mar 2024 |
|
BVF | 4.7M | $76M | 70% | Mar 2024 |
|
Canaan Partners XI | 4.4M | $72M | 0% | Mar 2024 |
|
Nextech Invest | 4.1M | $67M | 61% | Mar 2024 |
|
FMR | 4.0M | $65M | 2% | Mar 2024 |
|
Fairmount Funds Management | 1.4M | $23M | 0% | Mar 2024 |
|
BlackRock | 1.0M | $17M | 16% | Mar 2024 |
|
5AM Venture Management | 939k | $15M | 69% | Mar 2024 |
|
Vanguard Group | 900k | $15M | 19% | Mar 2024 |
|
Frazier Life Sciences Management | 832k | $14M | -19% | Mar 2024 |
|
OrbiMed Advisors | 769k | $13M | 100% | Mar 2024 |
|
Perceptive Advisors | 669k | $11M | 86% | Mar 2024 |
|
Sio Capital Management | 536k | $8.8M | 100% | Mar 2024 |
|
Kynam Capital Management | 515k | $8.4M | 51% | Mar 2024 |
|
Geode Capital Management | 417k | $6.8M | 33% | Mar 2024 |
|
First Turn Management | 381k | $6.3M | 100% | Mar 2024 |
|
Jpmorgan Chase & Co | 381k | $6.2M | -5% | Mar 2024 |
|
ExodusPoint Capital Management | 272k | $4.5M | 100% | Mar 2024 |
|
Northern Trust | 157k | $2.6M | 11% | Mar 2024 |
|
Charles Schwab Investment Management | 152k | $2.5M | 38% | Mar 2024 |
|
Wellington Management Company | 102k | $1.4M | 9% | Dec 2023 |
|
Auour Investments | 85k | $1.4M | 0% | Mar 2024 |
|
Oppenheimer & Co | 60k | $977k | 100% | Mar 2024 |
|
Victory Capital Management | 48k | $789k | -4% | Mar 2024 |
|
Bank of New York Mellon | 44k | $717k | 4% | Mar 2024 |
|
Two Sigma Investments | 42k | $685k | 100% | Mar 2024 |
|
Morgan Stanley | 35k | $578k | 93% | Mar 2024 |
|
Bank of America Corporation | 33k | $542k | 49% | Mar 2024 |
|
New York State Common Retirement Fund | 32k | $527k | 698% | Mar 2024 |
|
ADAR1 Capital Management | 28k | $464k | 100% | Mar 2024 |
|
Nuveen Asset Management | 26k | $422k | 37% | Mar 2024 |
|
American Century Companies | 25k | $409k | 100% | Mar 2024 |
|
Citadel Advisors | 21k | $346k | 100% | Mar 2024 |
|
Rhumbline Advisers | 21k | $344k | -2% | Mar 2024 |
|
Legato Capital Management | 20k | $332k | 100% | Mar 2024 |
|
Marshall Wace | 20k | $322k | -35% | Mar 2024 |
|
Walleye Trading Advisors | 17k | $277k | 100% | Mar 2024 |
|
Exchange Traded Concepts | 16k | $263k | 68% | Mar 2024 |
|
Fishman Jay A | 15k | $246k | 100% | Mar 2024 |
|
UBS Group | 14k | $232k | 185% | Mar 2024 |
|
Goldman Sachs Group | 14k | $231k | 100% | Mar 2024 |
|
Hudson Bay Capital Management | 13k | $218k | 100% | Mar 2024 |
|
PDT Partners | 12k | $200k | 100% | Mar 2024 |
|
Dimensional Fund Advisors | 11k | $176k | 1% | Mar 2024 |
|
Sepio Capital | 11k | $147k | 0% | Dec 2023 |
|
Baker Bros. Advisors | 11k | $174k | 0% | Mar 2024 |
|
Barclays | 9.9k | $161k | -49% | Mar 2024 |
|
MetLife Investment Advisors | 7.7k | $107k | 0% | Dec 2023 |
|
Citigroup | 7.1k | $117k | 250% | Mar 2024 |
|
Qube Research & Technologies | 7.0k | $115k | 100% | Mar 2024 |
|
American International | 7.0k | $96k | 0% | Dec 2023 |
|
Deutsche Bank Aktiengesellschaft | 6.0k | $99k | -3% | Mar 2024 |
|
Wells Fargo & Company | 4.7k | $78k | 16% | Mar 2024 |
|
Federated Investors | 2.1k | $29k | 1244% | Dec 2023 |
|
California State Teachers Retirement System | 1.4k | $23k | -54% | Mar 2024 |
|
Legal & General Group | 1.3k | $21k | 0% | Mar 2024 |
|
Summit Investment Advisors | 940.00 | $15k | 0% | Mar 2024 |
|
Metropolitan Life Insurance Company | 814.00 | $11k | 0% | Dec 2023 |
|
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 700.00 | $11k | 100% | Mar 2024 |
|
Ikarian Capital | 501.00 | $8.2k | -99% | Mar 2024 |
|
Amalgamated Bank | 424.00 | $7.0k | -71% | Mar 2024 |
|
Royal Bank of Canada | 320.00 | $0 | -92% | Mar 2024 |
|
Tower Research Capital | 144.00 | $2.4k | -83% | Mar 2024 |
|
Russell Investments | 126.00 | $2.1k | 563% | Mar 2024 |
|
Simplex Trading | 100.00 | $1.0k | 100% | Mar 2024 |
|
Pnc Financial Services | 58.00 | $951.002800 | 0% | Mar 2024 |
|
NISA Investment Advisors | 34.00 | $558.001200 | 112% | Mar 2024 |
|
GAMMA Investing | 16.00 | $262.000000 | 0% | Mar 2024 |
|
Nelson, Van Denburg & Campbell Wealth Management | 2.00 | $32.000000 | 100% | Mar 2024 |
|
CWM | 1.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Tyra Biosciences?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Woodline Partners | Sep 2023 | 410k | $5.7M |
EcoR1 Capital | Dec 2023 | 137k | $1.9M |
Mariner Wealth Advisors | Dec 2023 | 22k | $307k |
LPL Financial | Sep 2023 | 15k | $200k |
Susquehanna International | Sep 2023 | 12k | $164k |
Artia Global Partners | Dec 2023 | 10k | $142k |
AJOVista | Dec 2023 | 4.2k | $59k |